These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9366112)

  • 1. [Familial hematuric nephropathies].
    Gubler MC
    Rev Prat; 1997 Sep; 47(14):1545-9. PubMed ID: 9366112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alport syndrome or progressive hereditary nephritis with hearing loss].
    Gubler MC; Heidet L; Antignac C
    Nephrol Ther; 2007 Jun; 3(3):113-20. PubMed ID: 17540313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renal lesions of Alport syndrome.
    Heidet L; Gubler MC
    J Am Soc Nephrol; 2009 Jun; 20(6):1210-5. PubMed ID: 19470679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
    Chen N; Pan X; Ren H; Dong D
    Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant nephritis with renal failure of non-Alport type: clinical and molecular studies.
    Ilan T; Shohat T; Tobar A; Magal N; Yahav M; Halpern GJ; Rechavi G; Shohat M
    Isr Med Assoc J; 2001 Jul; 3(7):488-91. PubMed ID: 11791413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From Alport syndrome to benign familial hematuria: clinical and genetic aspect].
    Maziers N; Dahan K; Pirson Y
    Nephrol Ther; 2005 May; 1(2):90-100. PubMed ID: 16895672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in hereditary nephritis (Alport's syndrome).
    Bubalo FS; Davidson DD
    Indiana Med; 1991 Dec; 84(12):860-6. PubMed ID: 1774457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.
    Lemmink HH; Nillesen WN; Mochizuki T; Schröder CH; Brunner HG; van Oost BA; Monnens LA; Smeets HJ
    J Clin Invest; 1996 Sep; 98(5):1114-8. PubMed ID: 8787673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic mapping of X chromosome in the X-linked dominant inherited Alport's syndrome.
    Dai Y; Huang Y; He X; Wang S; Huang R; Tang M; Hu C
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):767-74. PubMed ID: 18711293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC; Yoon HS; Walker RJ; Eccles MR
    Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alport syndrome and diffuse leiomyomatosis. Clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis.
    Garcia-Torres R; Cruz D; Orozco L; Heidet L; Gubler MC
    Nephrologie; 2000; 21(1):9-12. PubMed ID: 10730274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal biopsy interpretation in Alport Syndrome.
    Mazzucco G; De Marchi M; Monga G
    Semin Diagn Pathol; 2002 Aug; 19(3):133-45. PubMed ID: 12180634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Collagen IV (alpha3-alpha4) nephropathy].
    Torra R; Tazón B; Ars E; Ballarín J
    Nefrologia; 2005; 25 Suppl 2():29-32. PubMed ID: 16050399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
    G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of family studies and kidney biopsies in children with renal hematuria].
    Pistor K; Bachmann H; Rumpelt HJ; Olbing H
    Monatsschr Kinderheilkd; 1985 May; 133(5):269-73. PubMed ID: 4010678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of collagen type IV nephropathies: from thin basement membrane nephropathy to Alport syndrome.
    Vizjak A; Ferluga D
    Srp Arh Celok Lek; 2008 Dec; 136 Suppl 4():323-6. PubMed ID: 20804103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COL4A3/COL4A4 mutations link familial hematuria and focal segmental glomerulosclerosis. glomerular epithelium destruction via basement membrane thinning?
    Voskarides K; Pierides A; Deltas C
    Connect Tissue Res; 2008; 49(3):283-8. PubMed ID: 18661361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.